24.08.2022 - Johnson & Johnson (NYSE: JNJ) today announced the appointment of Larry Merlo as Non-executive Chair Designate for the future, listed New Consumer Health Company’s Board of Directors. Merlo previously served as President and CEO of CVS Health and . Seite 1
/PRNewswire/ Johnson & Johnson (the "Company") (NYSE: JNJ) today announced the appointment of Thibaut Mongon as Chief Executive Officer Designate and Paul.
NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) announced Wednesday the appointment of Thibaut Mongon as Chief Executive Officer Designate and Paul Ruh as Chief Financial Officer Designate of
China-US economic and trade exchanges represent the foundation of their bilateral ties, and it is important for the two countries to enhance economic and trade relations based on equality and mutual respect, according to analysts and business leaders.